首页> 外国专利> ENDOGENOUS RETROVIRUS TRANSCRIPTION AS A MARKER FOR PRIMATE NAIVE PLURIPOTENT STEM CELLS

ENDOGENOUS RETROVIRUS TRANSCRIPTION AS A MARKER FOR PRIMATE NAIVE PLURIPOTENT STEM CELLS

机译:内源性逆转录转录作为原初幼体干细胞的标记

摘要

An in vitro method for identifying, isolating and/or enriching primate naive pluripotent stem cells, the method including analyzing transcription of a type 7 long terminal repeat (LTR7) nucleic acid sequence of a type H human endogenous retrovirus (HERVH) (LTR7/HERVH-associated transcription), and identifying, isolating and/or enriching primate naive pluripotent stem cells based on LTR7/HERVH-associated transcription, wherein LTR7/HERVH-associated transcription is a marker for primate naive pluripotent stem cells. An isolated in vitro population of primate naive pluripotent stem cells is obtained by the method, wherein in the cells LTR7/HERVH-associated transcription is elevated in comparison to control cells, wherein control cells are primed pluripotent stem cells or differentiated cells.
机译:一种鉴定,分离和/或富集灵长类幼稚多能干细胞的体外方法,该方法包括分析H型人内源性逆转录病毒(HERVH)(LTR7 / HERVH)的7型长末端重复(LTR7)核酸序列的转录-相关转录),并基于LTR7 / HERVH相关转录鉴定,分离和/或富集灵长类幼稚多能干细胞,其中LTR7 / HERVH相关转录是灵长类幼稚多能干细胞的标志物。通过该方法获得了分离的灵长类幼稚多能干细胞的体外群体,其中与对照细胞相比,在细胞中LTR7 / HERVH相关的转录升高,其中对照细胞是初免的多能干细胞或分化的细胞。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号